mTOR Signaling in Cardiometabolic Disease, Cancer, and Aging

Figure 1

Schematic representation of the mTOR signaling network (a) and the involvement of deregulated mTOR signaling in cardiovascular and metabolic disorders, in cancer and in aging (b), such as those highlighted in this special issue: myocardial ischemia/reperfusion injury, atherosclerosis, diabetes and its cardiac and vascular complications, tuberous sclerosis complex disease, and gynecological malignancies, among other types of cancers.